TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX)

CUSIP: 88032L605

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
18,453,093
Total 13F shares
4,720,738
Share change
+2,488,766
Total reported value
$35,929,590
Price per share
$7.61
Number of holders
34
Value change
+$18,970,280
Number of buys
20
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 88032L605?
CUSIP 88032L605 identifies TENX - TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX) as of Q3 2025

As of 30 Sep 2025, TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,720,738 shares. The largest 10 holders included Ikarian Capital, LLC, VR ADVISER, LLC, RTW INVESTMENTS, LP, Siren, L.L.C., BOOTHBAY FUND MANAGEMENT, LLC, BVF INC/IL, MILLENNIUM MANAGEMENT LLC, Vivo Capital, LLC, MORGAN STANLEY, and MARSHALL WACE, LLP. This page lists 34 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.